EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:753987 - epoetin beta
| ChEBI ID | CHEBI:753987 |
| ChEBI Name | epoetin beta |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antiviral agent A substance that destroys or inhibits replication of viruses. antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. |
| Applications: | anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. antiparkinson drug A drug used in the treatment of Parkinson's disease. renoprotective agent Any compound that is able to prevent damage to the kidneys. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. vulnerary A drug used in treating and healing of wounds. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| epoetin beta (CHEBI:753987) has role anti-anaemic agent (CHEBI:75835) |
| epoetin beta (CHEBI:753987) has role antimalarial (CHEBI:38068) |
| epoetin beta (CHEBI:753987) has role antineoplastic agent (CHEBI:35610) |
| epoetin beta (CHEBI:753987) has role antiparkinson drug (CHEBI:48407) |
| epoetin beta (CHEBI:753987) has role antipsychotic agent (CHEBI:35476) |
| epoetin beta (CHEBI:753987) has role antiviral agent (CHEBI:22587) |
| epoetin beta (CHEBI:753987) has role cardiovascular drug (CHEBI:35554) |
| epoetin beta (CHEBI:753987) has role immunosuppressive agent (CHEBI:35705) |
| epoetin beta (CHEBI:753987) has role neuroprotective agent (CHEBI:63726) |
| epoetin beta (CHEBI:753987) has role renoprotective agent (CHEBI:231911) |
| epoetin beta (CHEBI:753987) has role vulnerary (CHEBI:73336) |
| epoetin beta (CHEBI:753987) is a organic molecular entity (CHEBI:50860) |
| INNs | Source |
|---|---|
| epoetina beta | WHO MedNet |
| epoetine beta | WHO MedNet |
| Synonyms | Source |
|---|---|
| BM 06.019 | ChEMBL |
| EPOCH | ChEMBL |
| Epoetin beta | ChEMBL |
| Brand Names | Source |
|---|---|
| Neorecormon | ChEMBL |
| Neorecormon 1000 | ChEMBL |
| Neorecormon 10000 | ChEMBL |
| Neorecormon 2000 | ChEMBL |
| Neorecormon 20000 | ChEMBL |
| Neorecormon 3000 | ChEMBL |